1RAUTIO K, TAPANAINEN J S, RUOKONEN A, et al. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study [ J ]. Human Repro- duction ( Oxford, England), 2006,21 (6) : 1400-1407.
4AZZIZ R. Controversy in clinical endocrinology: diagnosis of poly- cystic ovarian syndrome: the Rotterdam criteria are premature[ J]. The Journal of Clinical Endocrinology and Metabolism, 2006, 91 (3) :781-785.
